Cephalexin has an important formal contraindication: known hypersensitivity to cephalexin or other cephalosporin-class antibacterial drugs. U.S. labeling also contains warnings concerning serious hypersensitivity, C. difficile-associated diarrhea, seizure risk in susceptible settings and other problems that require clinical evaluation. These categories should not be collapsed into a generic “avoid if unwell” message.
This page is a safety index for prescriber and pharmacy checks before a course. It explains the distinction between a contraindication, a warning and an interaction. Specific symptom details belong on the side-effects page, while the allergy page addresses reaction patterns and previous hypersensitivity.
Patients should provide complete allergy histories, current medications and information about kidney disease or prior antibiotic-associated colitis. Urgent new symptoms such as breathing difficulty, severe watery diarrhea, seizures or rapidly progressive rash require medical assessment rather than self-directed antibiotic switching.
The formal cephalexin contraindication in U.S. labeling concerns known hypersensitivity to cephalexin or another cephalosporin. Other situations—kidney impairment, possible antibiotic-associated colitis, medication interactions and certain bleeding-risk factors—may call for modified prescribing, laboratory checks or closer monitoring rather than an identical blanket prohibition.
The questions below direct readers to deeper material about cephalosporin allergy, renal function, and interacting medication. Identifying the type of warning matters more than matching a symptom to a generic “safe/unsafe” checklist.
| Your question | Relevant Core guide | Why open it |
|---|---|---|
| What about known allergy? | Known allergy | Contraindication and reaction assessment |
| What about penicillin history? | Penicillin history | Cross-reactivity considerations |
| What about adverse effects? | Adverse effects | Common versus serious reactions |
| What about kidney disease? | Kidney disease | Clearance and monitoring |
| What about interacting drugs? | Interacting drugs | Metformin, probenecid and tests |
| What about prescription review? | Prescription review | Safety checks before dispensing |
U.S. cephalexin prescribing information identifies known hypersensitivity to cephalexin or other cephalosporin antibacterial drugs as a contraindication. The record should be specific enough to explain the suspected medication and prior reaction. A severe immediate or delayed reaction should not be dismissed because another antibiotic was tolerated.
This is not the same as a general history of stomach upset after any antibiotic. The clinical team may need to review an uncertain label, but patients should not independently re-expose themselves to a medicine that may have caused a serious reaction.
Allergic reactions may include hives, swelling, difficulty breathing or other systemic symptoms, while some delayed skin reactions can be severe. Airway compromise, rapidly progressing rash with systemic illness or a severe mucocutaneous presentation warrants urgent evaluation.
Refer to the hypersensitivity guide for reaction-specific details. A symptom checklist is not a substitute for an emergency assessment, and a clinician must decide whether future cephalexin exposure is appropriate.
Cephalexin and other antibacterial agents can disturb intestinal flora and are associated with C. difficile-associated diarrhea. Serious diarrhea can develop during treatment or later; watery or bloody stools with abdominal pain or fever should not be ignored.
Contact a clinician promptly for concerning diarrhea and disclose recent antibiotic use even if the course has ended. The adverse-reaction guide covers common gastrointestinal complaints separately from these red flags.
Because cephalexin is cleared through the kidneys, impaired renal function can affect drug exposure and may require regimen changes. Cephalosporin-associated seizure reports are particularly relevant when renal clearance is reduced or exposure becomes excessive.
Tell the prescriber about kidney disease, dialysis or changing laboratory results. Never apply published renal dosing adjustments as a personal calculator. The renal guide explains professional assessment requirements.
The labeling identifies increased metformin exposure during concomitant cephalexin use and states that probenecid coadministration is not recommended. Certain older chemical urine-glucose tests can also be affected. These are interactions or laboratory caveats rather than the formal contraindication of cephalosporin allergy.
A pharmacist should reconcile all medicines and relevant tests with the current prescription. The drug interaction page covers those label findings in more detail without suggesting unsupervised medication changes.
In addition to allergy and kidney history, current cephalexin labeling warns that cephalosporins may be associated with prolonged prothrombin time. People with renal or hepatic impairment, poor nutritional status, prolonged antibacterial exposure, or anticoagulant therapy may merit laboratory monitoring as directed by a clinician. The warning is not a reason to independently stop a prescribed anticoagulant.
Tell the treating team about anticoagulants, significant liver disease, a history of serious antibiotic-associated diarrhea, seizure conditions and any prior severe drug reaction. The prescriber decides which factors affect the drug choice, monitoring or treatment duration. A pharmacy listing that omits these details is not a complete safety assessment.
The pharmacy should verify the correct drug, form, strength, directions, quantity and patient record before dispensing. A new or corrected allergy entry, drug interaction or kidney function finding may require the prescriber’s attention.
Report worsening infection or serious adverse symptoms. If treatment must be changed, the replacement antibiotic has distinct coverage and risks; an online buying guide should support legal prescription access without claiming medicines are automatically interchangeable.
Ask whether any recorded cephalosporin allergy is a formal contraindication; whether impaired kidney function warrants a dose or monitoring review; and whether use of metformin, probenecid or anticoagulants changes the follow-up plan. A past episode of severe antibiotic-associated diarrhea also deserves attention before another antibiotic course.
For a new concerning symptom, do not wait for a routine refill conversation. Seek urgent help for anaphylaxis signs, seizures or a severe progressive reaction, and promptly report significant diarrhea or unexplained bleeding. The side-effects guide covers symptoms after administration, while this page covers reasons for extra caution before and during treatment.
The pharmacy should reconcile the prescription with documented allergy, kidney function if known, other medicines and the exact ordered form. Product labeling describes clinical restrictions, but it does not verify that a patient’s chart contains complete safety information. An antibiotic request without appropriate prescribing assessment must not be treated as a shortcut around those checks.
Affiliate disclosure: Some partner referrals may compensate this site. Commercial links cannot override labelled contraindications, establish the safety of a new regimen or guarantee licensed pharmacy dispensing. Review prescribing and dispensing checks when a pharmacist needs to clarify an order.
Known cephalosporin hypersensitivity is a formal labeled contraindication. Kidney impairment, drug interactions, C. difficile-associated diarrhea, seizure risk and possible prolonged prothrombin time are separate safety considerations requiring situation-specific review.
For a current reaction seek appropriate medical care rather than relying on a contraindication list alone. For more detail on reactions see allergy or side effects.
Known hypersensitivity to cephalexin or other cephalosporin antibacterial drugs is a formal contraindication in U.S. labeling.
Not automatically in every circumstance, but the exact prior reaction requires careful assessment; CDC has specific immediate-type allergy restrictions for strep treatment.
Yes. C. difficile-associated diarrhea is a labeled warning and needs prompt assessment when symptoms are severe or persistent.
Impaired renal clearance can increase exposure and require clinician-directed dose adjustment or monitoring.
Yes. U.S. labeling does not recommend concurrent use because probenecid inhibits renal excretion.
No blanket pregnancy contraindication follows from the standard cephalosporin-hypersensitivity warning, but a patient-specific benefit-risk review is still needed.
No. Cephalexin only treats certain susceptible bacterial infections, and selection requires diagnosis and prescribing judgment.
Seek emergency medical assistance. This can be a sign of a serious hypersensitivity reaction.